Dr. Reddy’s Laboratories has announced the elevation of Akhil Ravi to lead the API and Services function, appointing him as Head API and Services and elevating him to Senior Management Personnel with induction into the company’s Management Council, effective November 13, 2026. The move underscores the company’s focus on strengthening its API and services leadership as it scales its CDMO footprint across discovery, biologics, APIs and peptides, while continuing to drive growth from its Aurigene Pharmaceutical Services Ltd. (APSL) subsidiary.